HIGHLIGHTS
- who: MVA modified vaccinia ankara et al. from the Oxford Vaccine Group, Department of Paediatrics and the NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, UK have published the research: Clinical and Experimental Immunology XX 1-11, in the Journal: (JOURNAL) of 30/Oct/2022
- what: The aims of this study were to identify ISG15 a transcriptomic signature in response to vaccination, and demonstrate which elements of this signature are linked to generation of desirable neutralizing antibody responses. The safety and immunogenicity of this vaccine have been previously assessed , this study seeks to characterise . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.